BR0307022A - Método de tratamento de um paciente que precisa de analgesia - Google Patents

Método de tratamento de um paciente que precisa de analgesia

Info

Publication number
BR0307022A
BR0307022A BR0307022-0A BR0307022A BR0307022A BR 0307022 A BR0307022 A BR 0307022A BR 0307022 A BR0307022 A BR 0307022A BR 0307022 A BR0307022 A BR 0307022A
Authority
BR
Brazil
Prior art keywords
analgesia
patient
treating
devazepide
needs
Prior art date
Application number
BR0307022-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Karen Jackson
Original Assignee
Ml Lab Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ml Lab Plc filed Critical Ml Lab Plc
Publication of BR0307022A publication Critical patent/BR0307022A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4468Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/55131,4-Benzodiazepines, e.g. diazepam or clozapine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Laser Surgery Devices (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Electrotherapy Devices (AREA)
  • Confectionery (AREA)
  • Radiation-Therapy Devices (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
BR0307022-0A 2002-01-22 2003-01-22 Método de tratamento de um paciente que precisa de analgesia BR0307022A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0201367.0A GB0201367D0 (en) 2002-01-22 2002-01-22 Composition
PCT/GB2003/000221 WO2003061632A1 (en) 2002-01-22 2003-01-22 Method of treatment of a patient requiring analgesia

Publications (1)

Publication Number Publication Date
BR0307022A true BR0307022A (pt) 2004-11-03

Family

ID=9929492

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0307022-0A BR0307022A (pt) 2002-01-22 2003-01-22 Método de tratamento de um paciente que precisa de analgesia

Country Status (13)

Country Link
EP (1) EP1467718B1 (https=)
JP (1) JP2005521655A (https=)
AT (1) ATE310509T1 (https=)
BR (1) BR0307022A (https=)
CA (1) CA2473884A1 (https=)
DE (1) DE60302431T2 (https=)
ES (1) ES2253662T3 (https=)
GB (1) GB0201367D0 (https=)
IL (1) IL162768A0 (https=)
MX (1) MXPA04007030A (https=)
NO (1) NO20042758L (https=)
PL (1) PL371523A1 (https=)
WO (1) WO2003061632A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0213198D0 (en) * 2002-06-10 2002-07-17 Ml Lab Plc Method of treatment
GB0406280D0 (en) * 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Chemical compounds
BRPI0520554A2 (pt) 2005-09-19 2009-06-13 Arrow Therapeutics Ltd uso de uma benzodiazepina ou um sal farmaceuticamente aceitável do mesmo, método para tratar ou prevenir uma infecção por hcv em um paciente, derivado de benzodiazepina ou um sal famaceuticamente aceitável do mesmo, e, composição farmacêutica
WO2008051889A1 (en) * 2006-10-24 2008-05-02 The Johns Hopkins University Rapid release mini-tablets provide analgesia in laboratory animals
EP2197448A4 (en) * 2007-09-12 2010-11-17 Elan Pharma Int Ltd dosing schedule
EP2611445B1 (en) * 2010-09-03 2018-08-15 Zoetis Belgium S.A. High dose buprenorphine compositions and use as analgesic
US20120171277A1 (en) * 2011-01-03 2012-07-05 Royds Robert B Abuse resistant transdermal drug delivery patch including a release-enhanced antagonist
US10729687B1 (en) 2019-07-09 2020-08-04 Orexo Ab Pharmaceutical composition for nasal delivery
US10653690B1 (en) 2019-07-09 2020-05-19 Orexo Ab Pharmaceutical composition for nasal delivery
RS63725B1 (sr) 2020-05-18 2022-12-30 Orexo Ab Nova farmaceutska kompozicija za davanje leka
GB202117016D0 (en) 2021-11-25 2022-01-12 Orexo Ab New pharmaceutical device
AR127780A1 (es) 2021-11-25 2024-02-28 Orexo Ab Nueva composición farmacéutica que comprende adrenalina
US12090151B1 (en) 2023-05-12 2024-09-17 Michael Guarnieri Injectable sustained release buprenorphine formulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1564039A (en) * 1976-12-09 1980-04-02 Berger F Analgesic compositions comprising dextropropoxyphene and benzodiazepines
US5153191A (en) * 1991-08-20 1992-10-06 Warner-Lambert Company Cholecystokinin antagonists useful for treating depression
GB9721746D0 (en) * 1997-10-15 1997-12-10 Panos Therapeutics Limited Compositions

Also Published As

Publication number Publication date
ATE310509T1 (de) 2005-12-15
WO2003061632A1 (en) 2003-07-31
GB0201367D0 (en) 2002-03-13
MXPA04007030A (es) 2004-10-11
CA2473884A1 (en) 2003-07-31
IL162768A0 (en) 2005-11-20
NO20042758L (no) 2004-09-22
EP1467718A1 (en) 2004-10-20
EP1467718B1 (en) 2005-11-23
DE60302431D1 (de) 2005-12-29
PL371523A1 (en) 2005-06-27
DE60302431T2 (de) 2006-07-27
JP2005521655A (ja) 2005-07-21
ES2253662T3 (es) 2006-06-01

Similar Documents

Publication Publication Date Title
WO2005058233A3 (en) Methods for treatment of acute pancreatitis
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
ATE292982T1 (de) Analgesiche synergie durch gleichzeitige verabreichung von subanalgesichen doseneines mu- opioidanagonisten und eines kappa - 2- opioidanagonisten
AU2003216321A1 (en) Tamper-resistant transdermal opioid delivery devices
NZ508526A (en) Opioid formulations for treating pain
WO2004056305A3 (en) Administration of capsaicinoids
WO2000021515A3 (en) Intranasal codeine for the rapid suppression of cough and rapid relief of pain
UA88270C2 (ru) Фармацевтический препарат и его применение для профилактики удара, диабета
BR0307022A (pt) Método de tratamento de um paciente que precisa de analgesia
WO2004039325A3 (en) Treatment of pain with jnk inhibitors
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
RO116771B1 (ro) Metodă pentru prevenirea sau tratamentul dependenţei, toleranţei sau abuzului de benzodiazepine
WO2002056745A3 (en) Method of treating parkinson's disease
GB0020504D0 (en) Therapeutic method
SE9902597D0 (sv) New use
MY126321A (en) Use of (alpha)-adrenoreceptor antagonists in the prevention and treatment of cancer.
DK1077683T3 (da) Antidepressiv behandling
BR9708037A (pt) Método para o tratamento de abuso de substância
TW200501958A (en) A therapeutic agent for treating a behavioral disorder
NO20043774L (no) The use of devazenide as analgesic agent
MXPA05011249A (es) Combinaciones de desoxipeganina y mecamilamina para el tratamiento del abuso de alcohol.
FI20010233A0 (fi) Menetelmä sydämen vajaatoiminnan hoitoon
PT1313500E (pt) Associacoes de dalfopristina/quinupristina com o cefpirome
DK0872238T3 (da) Anvendelse af olanzapin til fremstilling af et medikament til neuroprotektin
AR039862A1 (es) Uso de fexofenadina para la fabricacion de un medicamento para tratar un asma

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: INNOVATA PLC (GB)

Free format text: ALTERADO DE: ML LABORATORIES PLC

B25G Requested change of headquarter approved

Owner name: INNOVATA PLC (GB)

Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 020060170267/RJ DE 10/11/2006.

B25A Requested transfer of rights approved

Owner name: PANOS THERAPEUTICS LIMITED (GB)

Free format text: TRANSFERIDO DE: INNOVATA PLC

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADE(S)

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2116 DE 26/07/2011.